- Home
- BPT vs PRPH Comparison
BPT vs PRPH Comparison
Compare BPT & PRPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BPT
- PRPH
- Stock Information
- Founded
- BPT 1989
- PRPH 1989
- Country
- BPT United States
- PRPH United States
- Employees
- BPT N/A
- PRPH N/A
- Industry
- BPT Integrated oil Companies
- PRPH Biotechnology: Pharmaceutical Preparations
- Sector
- BPT Energy
- PRPH Health Care
- Exchange
- BPT Nasdaq
- PRPH Nasdaq
- Market Cap
- BPT 11.7M
- PRPH 10.7M
- IPO Year
- BPT N/A
- PRPH 1997
- Fundamental
- Price
- BPT $0.58
- PRPH $0.39
- Analyst Decision
- BPT
- PRPH
- Analyst Count
- BPT 0
- PRPH 0
- Target Price
- BPT N/A
- PRPH N/A
- AVG Volume (30 Days)
- BPT 137.7K
- PRPH 1.7M
- Earning Date
- BPT 05-08-2025
- PRPH 03-31-2025
- Dividend Yield
- BPT N/A
- PRPH N/A
- EPS Growth
- BPT N/A
- PRPH N/A
- EPS
- BPT N/A
- PRPH N/A
- Revenue
- BPT $236,000.00
- PRPH $6,770,000.00
- Revenue This Year
- BPT N/A
- PRPH N/A
- Revenue Next Year
- BPT N/A
- PRPH $64.06
- P/E Ratio
- BPT N/A
- PRPH N/A
- Revenue Growth
- BPT N/A
- PRPH N/A
- 52 Week Low
- BPT $0.40
- PRPH $0.22
- 52 Week High
- BPT $3.20
- PRPH $7.48
- Technical
- Relative Strength Index (RSI)
- BPT 51.70
- PRPH 45.88
- Support Level
- BPT $0.53
- PRPH $0.35
- Resistance Level
- BPT $0.60
- PRPH $0.60
- Average True Range (ATR)
- BPT 0.04
- PRPH 0.08
- MACD
- BPT 0.00
- PRPH 0.00
- Stochastic Oscillator
- BPT 41.91
- PRPH 27.59
About BPT BP Prudhoe Bay Royalty Trust
BP Prudhoe Bay Royalty Trust is a grantor trust operating in the US. The property of the Trust consists of an overriding royalty interest. The Royalty Interest entitles the Trust to receive the royalty from the production of crude oil and condensate from the working interest of BP Exploration (Alaska) Inc. in the Prudhoe Bay oil field located on the North Slope of Alaska.
About PRPH ProPhase Labs Inc. (DE)
ProPhase Labs Inc is a diversified company that offers a range of services including diagnostic testing, genomics testing and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers and government organizations. The Consumer products segment is engaged in the research, development, manufacture, distribution, marketing and sale of OTC consumer healthcare products and dietary supplements in the United States and also provide personal genomics products and services.